Estimating the number of relapsed and refractory indolent lymphoma patients across Europe, who are expected to initiate a new line of therapy (LOT)

Authors:

Ellis H, Neves C, Chapman A and Jeyakumaran D.

Publication type:

Poster PCN41

Conference name:

20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Ellis H, Neves C, Chapman A and Jeyakumaran D. Estimating the number of relapsed and refractory indolent lymphoma patients across Europe, who are expected to initiate a new line of therapy (LOT). 20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Glasgow, Scotland. 4-8 November. Poster PCN41.

Link to publication ⟶

⟵ Back to Search Results